Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000004

Director sold 2,800 shares at $45.00 ($126,000)

  • Director acquired 2,800 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-10 Exercise or conversion : show line 1 in the form 10b5-1 +110 $15.47 $1,702 12,656 D
2026-02-10 Sale : show line 2 in the form 10b5-1 −110 $45.00 $4,950 12,546 D
2026-02-12 Exercise or conversion : show line 3 in the form 10b5-1 +2,690 $15.47 $41,614 15,236 D
2026-02-12 Sale : show line 4 in the form 10b5-1 −2,690 $45.00 $121,050 12,546 D
Open-market sales · 2,800 sh · avg $45.00 · $126,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-10 Exercise or conversion : show line 5 in the form 10b5-1 Share Option −110 2,690 D
2026-02-12 Exercise or conversion : show line 6 in the form 10b5-1 Share Option −2,690 0 D
Loading xslF345X05/form4-02122026_090237.xml…